This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
  • 00
  • 00
  • 00
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Frederic Caroff
CEO at Hephaistos Pharma


Frederic Caroff is CEO at HEPHAISTOS-Pharma. He co-founded the company in 2018 and raised more than 8M€ in public and private funding for its development. Frederic is an engineer from Ecole Centrale Paris. He started his career as industrial scale-up manager. After a decade of high level management, he completed his training with an MBA at ESSEC Business School and started his first biotech company LPS-BIOSCIENCES, a contract research organization in the vaccine field. He successfully grew the company by negotiating several contracts and partnerships with big pharma companies.

HEPHAISTOS-Pharma is his second Biotech company, focusing on breakthrough therapeutic TLR4 immuno-stimulants, with the objective of curing patients with hard to treat tumors or metastatic cancers. As CEO, Frederic uses his entrepreneurial experience to negotiate partnership contracts with pharmaceutical companies.

Agenda Sessions

  • A new home: why Paris region is the ideal base to develop your biotech startups?